Industry analytics
Biological Products, (No Diagnostic Substances)
SIC 2836. A view of the 7 companies in this industry that Stratum has processed into structured data.
- Population
- 7 companiesSIC 2836 · 4 report USD revenue
- Period
- Latest year per companytrends by fiscal year, medians of whoever reported
- Geography
- 1 jurisdictionof incorporation
- Minimum group
- 3 companiessmaller groups show no statistic
- Combined revenue
- $87.9Msum of each company's latest annual USD revenue
- Median revenue growth
- -36.6%4 companies
- Median operating margin
- -372.1%5 companies
- Median net margin
- -348.5%5 companies
What is changing
Median by fiscal year across the companies that reported, with the middle half of companies shaded. A year needs 3 companies to be plotted.
No change in a median can be shown: fewer than two years have 3 or more companies reporting.
Operating margin
A trend needs at least two years with 3 or more companies; this group has 0.
Net margin
A trend needs at least two years with 3 or more companies; this group has 0.
Revenue growth
A trend needs at least two years with 3 or more companies; this group has 0.
How companies compare today
Each company's latest year. Bars are counts of companies; the dashed line is the median.
Operating margin · 5 companies
| Range | Companies |
|---|---|
| -462.3% to -444.2% | 1 |
| -444.2% to -426.1% | 0 |
| -426.1% to -408.0% | 0 |
| -408.0% to -389.9% | 0 |
| -389.9% to -371.8% | 2 |
| -371.8% to -353.7% | 0 |
| -353.7% to -335.6% | 0 |
| -335.6% to -317.5% | 1 |
| -317.5% to -299.4% | 0 |
| -299.4% to -281.3% | 0 |
| -281.3% to -263.2% | 0 |
| -263.2% to -245.1% | 1 |
25th -380.9% · median -372.1% · 75th -326.6%
2 of 5 companies lie outside the Tukey fences (-462.3% to -245.1%): 1 below, 1 above. They are flagged, not removed; every percentile and the table include them, and the end bins of the histogram count them.
Revenue growth · 4 companies
| Range | Companies |
|---|---|
| -51.8% to -37.7% | 2 |
| -37.7% to -23.6% | 1 |
| -23.6% to -9.5% | 0 |
| -9.5% to 4.7% | 0 |
| 4.7% to 18.8% | 0 |
| 18.8% to 32.9% | 0 |
| 32.9% to 47.0% | 0 |
| 47.0% to 61.1% | 0 |
| 61.1% to 75.2% | 0 |
| 75.2% to 89.3% | 0 |
| 89.3% to 103.4% | 0 |
| 103.4% to 117.5% | 1 |
25th -50.1% · median -36.6% · 75th 17.0%
1 of 4 companies lie outside the Tukey fences (-150.7% to 117.5%): 0 below, 1 above. They are flagged, not removed; every percentile and the table include them, and the end bins of the histogram count them.
Largest companies
By latest annual revenue reported in US dollars.
| Company | Revenue | Operating margin |
|---|---|---|
| Voyager Therapeutics, Inc.VYGR | $40.4MFY2025 | -326.6% |
| Metagenomi Therapeutics, Inc.MGX | $25.2MFY2025 | -380.9% |
| MICROMET, INC. | $21.9MFY2011 | -372.1% |
| VBI VACCINES INC. | $396.0KFY2015 | -3322.5% |
Where they are incorporated
Jurisdiction of incorporation from SEC records. It is not where sales or operations are.
1 company has no recognised jurisdiction code and is not counted here.
Recent reports
The latest filings by companies in this industry in the structured data layer.
AI interpretation
Describes what the statistics above show for Biological Products, (No Diagnostic Substances). The AI words statistics that were computed in code; it cannot add, change or estimate any figure, and each statement is checked before it is shown.